BioSpace News Archive

The global apheresis market is considered as a highly competitive market with a large number of players operating in it, states a new market intelligence study by Transparency Market Research.

Airway clearance techniques help clear thick mucus by coughing or huffing. This process of clearing the airway helps reduce chances of lung infections and improves lung functions.

Bushu Pharmaceuticals Ltd., one of Japan’s largest contract manufacturers of pharmaceutical products, announced on August 14 a major capital program costing $100 million to expand its footprint, capacity and portfolio of services.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes associated with product misuse, announced financial results for the three and six months ended June 30, 2020.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces financial results for the three and six months ended June 30, 2020 and provides a corporate update.

China Pharma Holdings, Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, announced financial results for the quarter ended June 30, 2020.

Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, announced its financial results for the second quarter ended June 30, 2020 and provided an update on recent corporate developments.

Bioequivalence study of VAZALORE 325 mg on track with top-line data demonstrating bioequivalence to immediate release aspirin

Microbix Biosystems Inc., an award-winning life sciences innovator and exporter, reports results for its third quarter and year to date fiscal 2020 ended June 30, 2020, with an increase of 141% in sales of Quality Assessment products.

Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has announced its second quarter financial results for the three and six months ended June 30 , 2020.